PBM

OptumRx DIR Fee Guide

4.7%

median DIR fee rate OptumRx charges independent pharmacies on Part D revenue

OptumRx position among major PBMs

OptumRx (UnitedHealth Group subsidiary) is the third-largest PBM by market share and has historically charged lower DIR rates than Caremark and Express Scripts. 2024 industry median: 4.7% (NCPA data).

Optum operates under a "vertical integration" model where UnitedHealth Group owns the health plan (UHC), the PBM (OptumRx), and the pharmacy service provider (OptumRx Home Delivery). Independent pharmacies compete with Optum's own captive pharmacy for share of UHC prescription volume.

DIR fees remain the primary clawback mechanism, but Optum also uses "steering" tactics — plan-design features that direct patients away from independent pharmacies toward Optum Home Delivery for maintenance medications.

The vertical integration problem

UnitedHealth Group's vertical integration creates a structural conflict: Optum's pricing decisions affect both plan sponsor costs (UHC) and PBM revenue (OptumRx) and captive pharmacy volume (OptumRx Home Delivery).

Practical impact for independents: UHC/Optum plans increasingly design 90-day maintenance fills to require Optum Home Delivery for lowest patient cost. Retail 30-day fills at independent pharmacies get penalty tier pricing (higher patient copay), pushing patients to switch to home delivery.

The 2023 Change Healthcare cyberattack (Change is another UnitedHealth subsidiary) demonstrated vertical integration risk — a single vendor outage disrupted 30-40% of US pharmacy claims processing for weeks.

Three Optum-specific tactics for independents

1. 90-day fill capture. For patients on Optum plans, offer 90-day fills at competitive cash-pay pricing. This retains the maintenance-Rx volume that would otherwise migrate to Optum Home Delivery. Cash-pay 90-day fills also have zero Optum DIR exposure.

2. PSAO leverage on UHC/Optum contracts. UHC/Optum contracts are typically less negotiable than Caremark/ESI, but Cardinal LEADER and McKesson Health Mart Atlas have negotiated modest DIR concessions for member pharmacies. Independents outside PSAOs typically pay full sticker DIR to Optum.

3. Star rating optimisation. Optum uses CMS 5-star ratings similarly to Caremark and ESI. Same lever applies: med-sync + adherence programs move stars 0.5-1 point within 6-12 months, reducing effective DIR rate by 15-30%.

See if Script Unlock is right for your pharmacy

Script Unlock is a cash-pay prescription marketplace where verified independent pharmacies compete for cash-paying patients. Every fill is 100% PBM-free revenue — no DIR, no GER, no MAC squeeze, no retroactive clawback.

Pharmacies typically move 15-30% of their Rx volume to cash-pay within 6 months of joining. On a 200-Rx/day pharmacy paying ~$150K/year in DIR fees, moving 25% of volume to cash-pay typically recovers $75K+/year in DIR-free revenue — 50× the $149/month subscription cost.

See if it fits your pharmacy Calculate your DIR losses

$149/month per location · No long-term contract · Free trial available

Frequently Asked Questions

Is OptumRx really cheaper than CVS Caremark?

On base DIR rate, yes — Optum's 4.7% median is meaningfully lower than Caremark's 6.8%. However, Optum's vertical integration (plan + PBM + captive pharmacy) creates additional volume loss risk via 90-day mail-order steering. Total economic impact on independents can be comparable across the three major PBMs.

What is Optum's home delivery threat?

UHC/Optum plans increasingly design maintenance medication (statins, BP meds, thyroid) to require Optum Home Delivery for lowest patient copay. Retail 30-day fills at independents get penalty pricing. This shifts 20-40% of chronic medication volume from independent retail to Optum captive mail-order over 2-3 years.

Can independents compete with Optum Home Delivery on price?

On 90-day cash-pay fills — yes, in many cases. Independent 90-day fill via cash-pay (through platforms like Script Unlock) often beats Optum Home Delivery for uninsured or high-deductible patients. On insured plans with mail-order-preferred design, independents lose the price battle by design.

Does Optum accept GER disputes?

Yes, but the process is less formalized than Express Scripts. Success rate on documented GER disputes is roughly 30% (lower than ESI's 40%). Documentation requirements are similar: therapeutic-class breakdown of generic dispensing rate with clinical rationale.

How does Change Healthcare fit into this?

Change Healthcare (owned by UnitedHealth Group since 2022) processes 30-40% of US pharmacy claims — an infrastructure monopoly created by acquisition. The February 2024 cyberattack demonstrated the concentration risk. No direct DIR impact but a systemic vulnerability affecting all pharmacy operations.

What's the highest-leverage Optum reduction tactic?

For most independents facing Optum exposure: capture the 90-day maintenance-Rx market via competitive cash-pay pricing. This defends volume that would otherwise migrate to Optum Home Delivery while eliminating Optum DIR on the captured volume. Cash-pay 90-day fills are also DIR-free and higher margin than 30-day insured fills.